1. Berglas S, Jutai L, MacKean G, Weeks L. Patients’ perspectives can be integrated in health technology assessments: an exploratory analysis of CADTH common drug review. Res Involv Engagem. 2016;2:21. doi:
10.1186/s40900-016-0036-9
.
2. Boivin A, Lehoux P, Burgers J, Grol R. What are the key ingredients for effective public involvement in health care improvement and policy decisions? A randomized trial process evaluation. Milbank Q. 2014;92:319–50.
3. CADTH-pCODR. Pan-Canadian oncology drug review: patient engagement guide. 2015.
https://www.cadth.ca/sites/default/files/pcodr/pCODR's%20Drug%20Review%20Process/pcodr-patient-engagement-guide.pdf
. Accessed 15 Nov 2016.
4. CADTH. Scientific advice. 2016.
https://www.cadth.ca/scientific-advice
. Accessed 13 June 2016.
5. Cowl J, Tyrrell H, Sakala C, Gracia J, Huang N. How to conduct public and targeted consultation. In: G-I-N public working group. G-I-N public toolkit: patient and public involvement in guidelines; 2015. p. 17–39.
http://www.g-i-n.net/document-store/working-groups-documents/g-i-n-public/toolkit/toolkit-2015
. Accessed 13 June 2016.